International Business News - ADLR http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Adolor Corp. said Thursday the Food and Drug Administration has lifted its clinical hold on the company's Entereg drug in chronically constipated patients taking opioid pain drugs. http://www.ibtimes.com/articles/20080703/fda-lifts-clinical-hold-on-adolor-bowel-drug.htm Thu, 03 Jul 2008 08:33:09 EDT More than 50 companies in the health care sector were added to the Russell 2000 in this year's reconstitution of the small stock index, while 30 companies in the sector were removed from the index. http://www.ibtimes.com/articles/20080630/russell-2000-adds-53-health-care-companies.htm Mon, 30 Jun 2008 14:16:09 EDT Biopharmaceutical company Adolor Corp. said Friday it appointed Stephen W. Webster as chief financial officer, effective on or about June 30. Webster succeeds Thomas Hess, who has resigned to pursue another business opportunity. http://www.ibtimes.com/articles/20080613/adolor-appoints-stephen-w-webster-as-cfo.htm Fri, 13 Jun 2008 15:18:31 EDT Wyeth and Progenics Pharmaceuticals Inc. said Thursday that early results from a late-stage trial of their drug Relistor did not meet its goal in restoring gastrointestinal function following surgery to the intestine. http://www.ibtimes.com/articles/20080522/wyeth-progenics-drug-misses-goal-in-late-stage-trial.htm Thu, 22 May 2008 09:40:50 EDT As growth slows in shares of large-cap biotechs and economic woes weigh on the broader markets, investors can find dramatic growth opportunities in many small and midcap biotechs who have secured lucrative research and development partnerships. http://www.ibtimes.com/articles/20080521/partnerships-drive-big-stock-gains-for-small-biotechs.htm Wed, 21 May 2008 16:58:51 EDT Shares of Adolor Corp. climbed to a fresh annual high Wednesday, after regulators approved its constipation treatment Entereg, but analysts were divided on sales prospects for the drug. http://www.ibtimes.com/articles/20080521/out-of-the-gate-adolor-jumps-on-entereg-approval.htm Wed, 21 May 2008 10:11:16 EDT Adolor Corp. said Friday that the Food and Drug Administration won't be making a decision on approval of the company's Entereg drug for post-surgery bowel blockage by Saturday, the scheduled action date. http://www.ibtimes.com/articles/20080509/adolor-says-fda-delays-decision-on-bowel-drug-entereg.htm Fri, 09 May 2008 08:50:56 EDT The Food and Drug Administration said Friday it will take up to three additional months to make a decision on Adolor Corp. and GlaxoSmithKline's anti-constipation drug candidate Entereg. http://www.ibtimes.com/articles/20080208/adolor-glaxo-drug-review-postponed.htm Fri, 08 Feb 2008 16:34:40 EST Government experts are scheduled to vote Wednesday on whether a drug made by Adolor Corp. should be approved in the U.S. to treat severe constipation following surgery. http://www.ibtimes.com/articles/20080123/ahead-of-the-bell-adolor-drug-reviewed.htm Wed, 23 Jan 2008 06:33:18 EST Pfizer Inc. reports earnings for the fourth quarter on Wednesday. The following is a summary of key developments and analyst opinion related to the period. http://www.ibtimes.com/articles/20080122/earnings-preview-pfizer.htm Tue, 22 Jan 2008 15:35:37 EST Adolor Corp. said Friday the Food and Drug Administration approved clinical trials for the biotechnology company's pain treatment candidate ADL5747. The company said it plans to start a Phase I, or early stage, study on the drug candidate in the first quarter. The drug is the second to enter development as part of a partnership with Pfizer Inc. The companies are already studying pain drug candidate ADL5859 in a mid-stage clinical trial. http://www.ibtimes.com/articles/20071228/adolor-pain-drug-study-gets-fda-approval.htm Fri, 28 Dec 2007 08:55:26 EST